- Home
- EE vs PAHC Comparison
EE vs PAHC Comparison
Compare EE & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EE
- PAHC
- Stock Information
- Founded
- EE 2003
- PAHC 1946
- Country
- EE United States
- PAHC United States
- Employees
- EE N/A
- PAHC N/A
- Industry
- EE Oil/Gas Transmission
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- EE Utilities
- PAHC Health Care
- Exchange
- EE Nasdaq
- PAHC Nasdaq
- Market Cap
- EE 805.1M
- PAHC 746.5M
- IPO Year
- EE 2022
- PAHC 2014
- Fundamental
- Price
- EE $29.36
- PAHC $23.39
- Analyst Decision
- EE Hold
- PAHC Sell
- Analyst Count
- EE 6
- PAHC 4
- Target Price
- EE $31.17
- PAHC $20.00
- AVG Volume (30 Days)
- EE 395.2K
- PAHC 245.7K
- Earning Date
- EE 05-07-2025
- PAHC 05-07-2025
- Dividend Yield
- EE 0.82%
- PAHC 2.03%
- EPS Growth
- EE 37.63
- PAHC 140.17
- EPS
- EE 1.53
- PAHC 0.78
- Revenue
- EE $966,414,000.00
- PAHC $1,190,682,000.00
- Revenue This Year
- EE $13.96
- PAHC $27.84
- Revenue Next Year
- EE $39.55
- PAHC $10.22
- P/E Ratio
- EE $19.20
- PAHC $30.32
- Revenue Growth
- EE N/A
- PAHC 19.12
- 52 Week Low
- EE $16.70
- PAHC $16.06
- 52 Week High
- EE $32.99
- PAHC $26.55
- Technical
- Relative Strength Index (RSI)
- EE 63.33
- PAHC 66.11
- Support Level
- EE $24.76
- PAHC $23.17
- Resistance Level
- EE $30.10
- PAHC $24.87
- Average True Range (ATR)
- EE 0.92
- PAHC 0.91
- MACD
- EE 0.49
- PAHC 0.67
- Stochastic Oscillator
- EE 86.05
- PAHC 78.42
About EE Excelerate Energy Inc.
Excelerate Energy Inc offers LNG solutions, providing integrated services along the LNG value chain. It offers a full range of regasification services, from FSRUs to infrastructure development, to LNG and natural gas supply. Its business spans the globe, with a regional presence in 11 countries and an operational presence in Argentina, Bangladesh, Brazil, Finland, Germany, Pakistan, the United Arab Emirates (UAE), and the United States.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.